z-logo
open-access-imgOpen Access
A Randomized Trial of Sibutramine in the Management of Obese Type 2 Diabetic Patients Treated With Metformin
Author(s) -
Steven McNulty,
Ehud Ur,
Gareth Williams
Publication year - 2003
Publication title -
diabetes care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.636
H-Index - 363
eISSN - 1935-5548
pISSN - 0149-5992
DOI - 10.2337/diacare.26.1.125
Subject(s) - medicine , sibutramine , metformin , placebo , weight loss , glycemic , type 2 diabetes , blood pressure , diabetes mellitus , endocrinology , randomized controlled trial , obesity , alternative medicine , pathology
To evaluate the effects of sibutramine (15 and 20 mg/day) on weight, metabolic control, and blood pressure in metformin-treated obese subjects with type 2 diabetes.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom